1. Home
  2. QCOM vs NVS Comparison

QCOM vs NVS Comparison

Compare QCOM & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QUALCOMM Incorporated

QCOM

QUALCOMM Incorporated

HOLD

Current Price

$218.82

Market Cap

158.8B

Sector

Technology

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$148.64

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QCOM
NVS
Founded
1985
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.8B
286.5B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
QCOM
NVS
Price
$218.82
$148.64
Analyst Decision
Buy
Hold
Analyst Count
23
5
Target Price
$160.09
$144.00
AVG Volume (30 Days)
21.1M
1.3M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
2.36%
2.16%
EPS Growth
N/A
N/A
EPS
9.65
N/A
Revenue
$44,284,000,000.00
N/A
Revenue This Year
$0.73
$2.30
Revenue Next Year
$0.48
$5.27
P/E Ratio
$25.13
$23.13
Revenue Growth
13.66
N/A
52 Week Low
$121.99
$112.34
52 Week High
$259.92
$170.46

Technical Indicators

Market Signals
Indicator
QCOM
NVS
Relative Strength Index (RSI) 51.64 49.64
Support Level $161.69 $145.30
Resistance Level $253.91 $152.55
Average True Range (ATR) 17.60 1.93
MACD -2.21 -0.25
Stochastic Oscillator 37.34 59.99

Price Performance

Historical Comparison
QCOM
NVS

About QCOM QUALCOMM Incorporated

Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: